Minute Insight: Indigo Diabetes Starts Human Trial Of Subcutaneous Glucose Monitor
The company has enrolled the first patient in the second human trial of its implantable metabolite monitoring system, which it expects could change the game for blood glucose measurement.
You may also be interested in...
Nutromics is working on a portfolio of aptamer-based sensors capable of measuring a wide range of analytes found in interstitial fluid.
Medtech Insight has spoken to several companies aiming to release devices that will replace current blood glucose monitors via disruptive, innovative technologies.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.